Literature DB >> 19597128

Oxidative stress enhances toll-like receptor 3 response to double-stranded RNA in airway epithelial cells.

Akira Koarai1, Hisatoshi Sugiura, Satoru Yanagisawa, Tomohiro Ichikawa, Yoshiaki Minakata, Kazuto Matsunaga, Tsunahiko Hirano, Keiichiro Akamatsu, Masakazu Ichinose.   

Abstract

Virus infections are a major cause of chronic obstructive pulmonary disease (COPD) exacerbations. Recently, Toll-like receptor 3 (TLR3) has been demonstrated to react to double-stranded RNA (dsRNA) and to be involved in the immune responses after viral infections. In the present study, we examined whether oxidative stress, which is involved in the pathogenesis of COPD, enhances the responses of TLR3 in airway epithelial cells. The effect of hydrogen peroxide (H(2)O(2)) on the release of IL-8 from BEAS-2B cells and primary human bronchial epithelial cells after stimulation with polyinosine-polycytidylic acid [poly(I:C)], a synthetic analog of viral dsRNA and a ligand for TLR3, and the signal transduction were examined. One hundred to 150 muM H(2)O(2) significantly potentiated the release of IL-8 from the epithelial cells after stimulation with 10 microg/ml poly(I:C). The H(2)O(2)-augmented IL-8 release was inhibited by treatment with N-acetylcysteine. One hundred micromoles of H(2)O(2) enhanced the translocation of nuclear factor (NF)-kappaB p65, but not that of interferon regulatory factor-3 (IRF-3), into the nucleus and the NF-kappaB DNA binding activity after poly(I:C) stimulation, which effect was inhibited not by the silencing of IRF-3 but by MG132, a proteasome inhibitor, or dexamethasone. One hundred micromoles of H(2)O(2) potentiated the TLR3 expression on the airway epithelial cells treated with poly(I:C). These data suggest that oxidative stress augments the response of TLR3 in airway epithelial cells via NF-kappaB and that this effect might be partly mediated by the enhancement of TLR3 expression. Modulation of this pathway may be a therapeutic target for viral-induced exacerbations of COPD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19597128      PMCID: PMC2891495          DOI: 10.1165/rcmb.2008-0345OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  50 in total

1.  Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial.

Authors:  L Davies; R M Angus; P M Calverley
Journal:  Lancet       Date:  1999-08-07       Impact factor: 79.321

Review 2.  COPD exacerbations . 2: aetiology.

Authors:  E Sapey; R A Stockley
Journal:  Thorax       Date:  2006-03       Impact factor: 9.139

3.  Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease.

Authors:  T A Seemungal; G C Donaldson; A Bhowmik; D J Jeffries; J A Wedzicha
Journal:  Am J Respir Crit Care Med       Date:  2000-05       Impact factor: 21.405

4.  Cytokine-mediated xanthine oxidase upregulation in chronic obstructive pulmonary disease's airways.

Authors:  Yuichi Komaki; Hisatoshi Sugiura; Akira Koarai; Masafumi Tomaki; Hiromasa Ogawa; Takefumi Akita; Toshio Hattori; Masakazu Ichinose
Journal:  Pulm Pharmacol Ther       Date:  2005       Impact factor: 3.410

Review 5.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

6.  Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus.

Authors:  Loïc Guillot; Ronan Le Goffic; Sarah Bloch; Nicolas Escriou; Shizuo Akira; Michel Chignard; Mustapha Si-Tahar
Journal:  J Biol Chem       Date:  2004-12-03       Impact factor: 5.157

7.  Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease.

Authors:  Yusheng Qiu; Jie Zhu; Venkata Bandi; Robert L Atmar; Keith Hattotuwa; Kay K Guntupalli; Peter K Jeffery
Journal:  Am J Respir Crit Care Med       Date:  2003-07-11       Impact factor: 21.405

8.  Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease.

Authors:  G C Donaldson; T A R Seemungal; A Bhowmik; J A Wedzicha
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

9.  Tobacco smoking inhibits expression of proinflammatory cytokines and activation of IL-1R-associated kinase, p38, and NF-kappaB in alveolar macrophages stimulated with TLR2 and TLR4 agonists.

Authors:  Haiyan Chen; Mark J Cowan; Jeffrey D Hasday; Stefanie N Vogel; Andrei E Medvedev
Journal:  J Immunol       Date:  2007-11-01       Impact factor: 5.422

10.  Multiple TLRs activate EGFR via a signaling cascade to produce innate immune responses in airway epithelium.

Authors:  Jonathan L Koff; Matt X G Shao; Iris F Ueki; Jay A Nadel
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-03-28       Impact factor: 5.464

View more
  22 in total

Review 1.  Are reactive oxygen species always detrimental to pathogens?

Authors:  Claudia N Paiva; Marcelo T Bozza
Journal:  Antioxid Redox Signal       Date:  2013-10-26       Impact factor: 8.401

Review 2.  Cellular stress response and innate immune signaling: integrating pathways in host defense and inflammation.

Authors:  Sujatha Muralidharan; Pranoti Mandrekar
Journal:  J Leukoc Biol       Date:  2013-08-29       Impact factor: 4.962

3.  The Induction of Pattern-Recognition Receptor Expression against Influenza A Virus through Duox2-Derived Reactive Oxygen Species in Nasal Mucosa.

Authors:  Hyun Jik Kim; Chang-Hoon Kim; Min-Ji Kim; Ji-Hwan Ryu; Sang Yeop Seong; Sujin Kim; Su Jin Lim; Michael J Holtzman; Joo-Heon Yoon
Journal:  Am J Respir Cell Mol Biol       Date:  2015-10       Impact factor: 6.914

4.  Pseudomonas aeruginosa suppresses interferon response to rhinovirus infection in cystic fibrosis but not in normal bronchial epithelial cells.

Authors:  Sangbrita S Chattoraj; Shyamala Ganesan; Andrea Faris; Adam Comstock; Wai-Ming Lee; Umadevi S Sajjan
Journal:  Infect Immun       Date:  2011-08-08       Impact factor: 3.441

5.  The presence of Torque teno virus in chronic obstructive pulmonary disease.

Authors:  Bahadır Feyzioğlu; Turgut Teke; Mehmet Ozdemir; Adnan Karaibrahimoğlu; Metin Doğan; Mehmet Yavşan
Journal:  Int J Clin Exp Med       Date:  2014-10-15

6.  Hyperglycemia, oxidative and nitrosative stress affect antiviral, inflammatory and apoptotic signaling of cultured thymocytes.

Authors:  G Kocic; D Sokolovic; T Jevtovic; A Veljkovic; R Kocic; G Nikolic; J Basic; D Stojanovic; A Cencic; S Stojanovic
Journal:  Redox Rep       Date:  2010       Impact factor: 4.412

7.  Requirement of NOX2 and reactive oxygen species for efficient RIG-I-mediated antiviral response through regulation of MAVS expression.

Authors:  Anton Soucy-Faulkner; Espérance Mukawera; Karin Fink; Alexis Martel; Loubna Jouan; Yves Nzengue; Daniel Lamarre; Christine Vande Velde; Nathalie Grandvaux
Journal:  PLoS Pathog       Date:  2010-06-03       Impact factor: 6.823

8.  TLR2, TLR3, and TLR4 activation specifically alters the oxidative status of intestinal epithelial cells.

Authors:  Eva Latorre; Carmen Mendoza; Elena Layunta; Ana I Alcalde; José E Mesonero
Journal:  Cell Stress Chaperones       Date:  2013-09-26       Impact factor: 3.667

Review 9.  Respiratory syncytial virus infection: mechanisms of redox control and novel therapeutic opportunities.

Authors:  Roberto P Garofalo; Deepthi Kolli; Antonella Casola
Journal:  Antioxid Redox Signal       Date:  2012-09-07       Impact factor: 8.401

10.  Reactive oxygen species induce antiviral innate immune response through IFN-λ regulation in human nasal epithelial cells.

Authors:  Hyun Jik Kim; Chang-Hoon Kim; Ji-Hwan Ryu; Min-Ji Kim; Chong Yoon Park; Jae Myun Lee; Michael J Holtzman; Joo-Heon Yoon
Journal:  Am J Respir Cell Mol Biol       Date:  2013-11       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.